Skip to main content

Advertisement

Log in

Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Hyperglycaemia caused by stress and inflammation is common during critical illness. We hypothesised that a latent glucose metabolism disturbance contributes to development of hyperglycaemia and that those patients have increased risk for diabetes. We included patients with sepsis, acute coronary syndrome and acute heart failure with no history of impaired glucose metabolism and divided them in the hyperglycaemia group (glucose ≥ 7.8 mmol/l) and normoglycaemia group. Patients were followed for 5 years. Follow-up was completed for 115 patients in the normoglycaemia group, of which 4 (3.5%) developed type 2 diabetes. In the hyperglycaemia group 51 patients finished follow-up and 8 (15.7%) developed type 2 diabetes. Relative risk in 5-year period for patients with hyperglycaemia was 4.51 for development of type 2 diabetes. Patients with hyperglycaemia during critical illness who are not diagnosed with diabetes before or during the hospitalisation should be considered a population at increased risk for developing diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554

    Article  CAS  PubMed  Google Scholar 

  2. Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688

    Article  PubMed  Google Scholar 

  3. van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367

    Article  PubMed  Google Scholar 

  4. Malmberg K, Norhammar A, Wedel H et al (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632

    CAS  PubMed  Google Scholar 

  5. Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528

    Article  PubMed  Google Scholar 

  6. Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix

    Google Scholar 

  7. McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124

    Article  CAS  PubMed  Google Scholar 

  8. Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559

    Article  CAS  PubMed  Google Scholar 

  9. Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383

    Article  CAS  PubMed  Google Scholar 

  10. Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756

    Article  PubMed  Google Scholar 

  11. Aljada A, Ghanim H, Assian E et al (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491

    Article  CAS  PubMed  Google Scholar 

  12. Mizock BA (2001) Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533–551

    Article  CAS  PubMed  Google Scholar 

  13. Clowes GH Jr, Martin H, Walji S et al (1978) Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577–583

    Article  CAS  PubMed  Google Scholar 

  14. Dahn MS, Jacobs LA, Smith S et al (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172

    CAS  PubMed  Google Scholar 

  15. Mehta VK, Hao W, Brooks-Worrell BM et al (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214

    Article  CAS  PubMed  Google Scholar 

  16. Metso AJ, Murros K (2007) Hyperglycaemia and the outcome of stroke. Brain 130:e85 (author reply e86)

    Article  PubMed  Google Scholar 

  17. Cubbon RM, Rajwani A, Abbas A et al (2007) Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 14:666–671

    Article  PubMed  Google Scholar 

  18. American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60

    Google Scholar 

  19. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538

    PubMed  Google Scholar 

  20. Pollack CV Jr, Braunwald E (2008) 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51:591–606

    Article  PubMed  Google Scholar 

  21. Braunwald E, Antman EM, Beasley JW et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970–1062

    Article  CAS  PubMed  Google Scholar 

  22. Goran KP (2007) The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 28:2042 (author reply 2042–2043)

    Article  PubMed  Google Scholar 

  23. Deedwania P, Kosiborod M, Barrett E et al (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619

    Article  PubMed  Google Scholar 

  24. Inzucchi SE, Rosenstock J (2005) Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 28:976–979

    Article  PubMed  Google Scholar 

  25. Bryer-Ash M, Garber AJ (2005) Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 28:973–975

    Article  PubMed  Google Scholar 

  26. Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10(Suppl 2):4–9

    PubMed  Google Scholar 

  27. Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Gornik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gornik, I., Vujaklija, A., Lukić, E. et al. Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus. Acta Diabetol 47 (Suppl 1), 29–33 (2010). https://doi.org/10.1007/s00592-009-0115-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-009-0115-6

Keywords

Navigation